Work

AB0383 COMPARISON OF EFFICACY AND SAFETY IN JAK INHIBITOR DUE TO A DIFFERENCE OF SELECTIVITY – TOFACITINIB vs. BARICITINIB –

Year: 2022

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2022-eular.129

Authors: I. Yoshii, N. Sawada, T. Chijiwa

Institutions: Dogo Onsen Hospital, Japanese Red Cross Kochi Hospital

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4283708563

Cites:

Cited by: 2

Related to: 10